2026
article
OpenAlex
María González‐Esguevillas, Aaron F. Baldwin, Pablo J. Cabrera, Yanfei Guan et autres
Abstract Ibuzatrelvir is an orally bioavailable, next-generation clinical candidate developed for the treatment of COVID-19 infections. It was identified during the pandemic, prior to the approval of PAXLOVID, and displays a more favorable pharmacokinetic profile than nirmatrelvir. Consequently, the initial development of …
us
(code pays fourni par la source)
2026
article
OpenAlex
Ijaz Ahmed, Russell F. Algera, Aaron F. Baldwin, Andrew M. Derrick et autres
Abstract The target compound danuglipron belongs to a family of glucagon-like peptide-1 receptor agonist (GLP-1RA) candidates identified in the Pfizer laboratories for the treatment of type 2 diabetes mellitus and obesity. This article describes a development approach providing a data-centric, holistic methodology …
us, gb, ie
(code pays fourni par la source)
2026
article
OpenAlex
Russell F. Algera, Nahian Khan, Philipp C. Roosen
Fundamental properties including solubility and structure–reactivity correlations of potassium tert -butoxide (KO t Bu) are described in this manuscript. A combination of donor solvent titration, diffusion NMR, and DFT studies established that KO t Bu exists in one of three solution structures: …
us
(code pays fourni par la source)